Blog
The next era of AI in drug discovery
Key takeaways and insights from Mark Hahnel’s keynote speech at AI in Drug Discovery hubXchange 2026
-
-
BlogIn Life Sciences, data integrity is non-negotiable
This first of a new series – Inside Our Data – explores the foundational data infrastructure that makes trust possible -
BlogA double-edged sword: the growing complexity of Medical Affairs publication performance data
When unique, Medical Affairs-relevant data sources come already embedded, the diversity of data is no longer an obstacle -
BlogShow your sources: building verifiable, citable AI agents with MCP
Our new Dimensions & Altmetric MCPs ground LLMs in structured data, generating verified, citable results that research teams can trust -
BlogNo Gold Standard: Measuring Success in Medical Affairs
To understand true publication impact – and influence patient outcomes – Medical Affairs teams must have their own benchmarks -
BlogFrom writing the rules to building the tools: Responsible research assessment in practice
What does responsible research assessment actually ask of the people who build the infrastructure, rather than those who write the… -
BlogResearch strategy deserves better than a chatbot: Why Dimensions Research Strategy is different from other AI tools in research
The AI analytics platform built to think through complex strategic questions the way a skilled research domain expert would -… -
BlogREF readiness: evidencing Strategy, People & Research Environment
We explore what it takes to evidence Strategy, People & Research Environment for the Research Excellence Framework (REF) 2029 -
BlogWhy your AI agents are only as good as the knowledge behind them
If context is the key to building reliable AI agents, how can that context layer be strengthened and improved? -
BlogREF readiness: evidencing Contribution to Knowledge & Understanding
We explore what it takes to evidence Contribution to Knowledge & Understanding for the Research Excellence Framework (REF) 2029 -
BlogFrom The Lancet to BlueSky: Benchmarking success for publication strategy in medical affairs
Medical affairs teams need an omnichannel approach to planning and monitoring publication strategy. Enter: Compass by Dimensions -
BlogWhy the future of Pharma data can only be FAIR
FAIR data is a defining component for a future-proofed pharma or life science enterprise. But what is FAIR data, and…